Characterization of the putative operon containing arylamine N−acetyltransferase (nat) in Mycobacterium bovis BCG

Characterization of the putative operon containing arylamine N−acetyltransferase (nat) in Mycobacterium bovis BCG

Mycobacterium bovis BCG and Mycobacterium tuberculosis possess a single arylamine N-acetyltransferase whose gene is predicted to occur within a six-gene operon. Deletion of the nat gene caused an extended lag phase in M. bovis BCG and a cell morphology associated with an altered pattern of cell wall...

Full description

Bibliographic Details
Main Author:	Eltis, E
Format:	Journal article
Published:	2006

Similar Items

Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG.
by: Anderton, M, et al.
Published: (2006)

Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis.
by: Fullam, E, et al.
Published: (2009)

Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
by: Kawamura, A, et al.
Published: (2003)

Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs).
by: Brooke, E, et al.
Published: (2003)

Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site.
by: Abuhammad, A, et al.
Published: (2010)

Protein-ligand interactions of arylamine N-acetyltransferase from Mycobacterium smegmatis
by: Brooke, E
Published: (2003)

Structure and mechanism of arylamine N-acetyltransferases.
by: Westwood, I, et al.
Published: (2006)

Mapping the genes for arylamine N-acetyltransferases
by: Fakis, G
Published: (2000)

Structural Studies on the Mycobacterial Arylamine N-Acetyltransferases
by: Abuhammad, A, et al.
Published: (2010)

Arylamine N-acetyltransferase in adult mouse brain
by: Mo, M, et al.
Published: (2004)

Expression of the genes for arylamine N-acetyltransferases in mice
by: Boukouvala, S, et al.
Published: (2002)

Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine system.
by: Wakefield, L, et al.
Published: (2008)

Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
by: Sim, E, et al.
Published: (2008)

Neuroendocrine expression of mouse arylamine N-acetyltransferase 2
by: Wakefield, L, et al.
Published: (2006)

Chromosome mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: identification of a novel upstream noncoding exon for murine Nat2.
by: Fakis, G, et al.
Published: (2000)

Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
by: Laurieri, N, et al.
Published: (2014)

Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1.
by: Wang, H, et al.
Published: (2005)

An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases.
by: Brooke, E, et al.
Published: (2003)

Arylamine N-acetyltransferase expression during murine heart development
by: Wakefield, L, et al.
Published: (2004)

Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population
by: Hiba Chelouti, et al.
Published: (2017-08-01)

Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.
by: Russell, A, et al.
Published: (2009)

The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
by: Sandy, J, et al.
Published: (2002)

Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer
by: Amjad Mahasneh, et al.
Published: (2012-01-01)

Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.
by: Westwood, I, et al.
Published: (2010)

Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
by: Kawamura, A, et al.
Published: (2005)

Mechanisms of cell accumulation induced by Mycobacterium bovis BCG
by: Octávio Menezes-de-Lima-Júnior, et al.
Published: (1997-12-01)

Non-coding and intergenic genetic variants of human arylamine N-acetyltransferase 2 (NAT2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders
by: Kyung U. Hong, et al.
Published: (2023-04-01)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris.
by: Madikane, V, et al.
Published: (2007)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris
by: Madikane, V, et al.
Published: (2007)

Auxotrophic <i>Mycobacterium bovis</i> BCG: Updates and Perspectives
by: Odir Antônio Dellagostin, et al.
Published: (2022-05-01)

Structure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversity.
by: Abuhammad, A, et al.
Published: (2013)

Hamster arylamine N-acetyltransferase 2: Investigation of substrate specificity by high-through-put screening
by: Kawamura, A, et al.
Published: (2004)

Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.
by: Westwood, I, et al.
Published: (2011)

Arylamine N-Acetyltransferases from mycobacteria: investigations of a potential yarget for anti-tubercular therapy
by: Abuhammad, A
Published: (2013)

Optimisation of <i>Mycobacterium bovis</i> BCG Fermentation and Storage Survival
by: Jordan Pascoe, et al.
Published: (2020-09-01)

Detailed Structural Analysis of the Immunoregulatory Polysaccharides from the Mycobacterium Bovis BCG
by: Lan Luo, et al.
Published: (2022-09-01)

Proteoliposomes from mycobacterium bovis BCG and mycobacterium smegmatis as new vaccine candidates against tuberculosis
by: Kadir, Ramlah
Published: (2016)

Determination of residual virulence and immunogenicity of Mycobacterium bovis BCG-1 seed lots
by: D. T. Levi, et al.
Published: (2018-02-01)

Specific and non-specific effects of Mycobacterium bovis BCG vaccination in dairy calves
by: Catalina Contreras, et al.
Published: (2023-10-01)

Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.
by: Adam, P, et al.
Published: (2003)